The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems

被引:57
作者
Kumar, Raj [1 ]
Dhaliwal, Harkiran Preet [2 ]
Kukreja, Roshan Vijay [1 ]
Singh, Bal Ram [1 ,3 ]
机构
[1] Inst Adv Sci, Botulinum Res Ctr, 78-540 Faunce Corner Mall Rd, N Dartmouth, MA 02747 USA
[2] Univ Massachusetts, Biomed Engn & Biotechnol, Dartmouth, MA USA
[3] Prime Bio Inc, Dartmouth, MA USA
基金
美国国家卫生研究院;
关键词
botulinum neurotoxin; sensory neurons; longevity; SNAP-25; neurotransmitter; RECEPTOR-BINDING-SITE; NEUROTOXIN-COMPLEX; PROTEIN-RECEPTOR; TYROSINE PHOSPHORYLATION; ACETYLCHOLINE-RELEASE; GANGLION NEURONS; B NEUROTOXIN; AMINO-ACID; INHIBITION; SNAP-25;
D O I
10.1055/s-0035-1571215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Botulinum neurotoxin (BoNT) produced by Clostridium botulinum is the most potent molecule known to mankind. Higher potency of BoNT is attributed to several factors, including structural and functional uniqueness, target specificity, and longevity. Although BoNT is an extremely toxic molecule, it is now increasingly used for the treatment of disorders related to muscle hyperactivity and glandular hyperactivity. Weakening of muscles due to peripheral action of BoNT produces a therapeutic effect. Depending on the target tissue, BoNT can block the cholinergic neuromuscular or cholinergic autonomic innervation of exocrine glands and smooth muscles. In recent observations of the analgesic properties of BoNT, the toxin modifies the sensory feedback loop to the central nervous system. Differential effects of BoNT in excitatory and inhibitory neurons provide a unique therapeutic tool. In this review the authors briefly summarize the structure and mechanism of actions of BoNT on motor and sensory neurons to explain its therapeutic effects and future potential.
引用
收藏
页码:10 / 19
页数:10
相关论文
共 123 条
  • [1] Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle
    Adler, M
    Keller, JE
    Sheridan, RE
    Deshpande, SS
    [J]. TOXICON, 2001, 39 (2-3) : 233 - 243
  • [2] Transsynaptic inhibition of spinal transmission by A2 botulinum toxin
    Akaike, Norio
    Shin, Min-Chul
    Wakita, Masahito
    Torii, Yasushi
    Harakawa, Tetsuhiro
    Ginnaga, Akihiro
    Kato, Keiko
    Kaji, Ryuji
    Kozaki, Shunji
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2013, 591 (04): : 1031 - 1043
  • [3] Evidence for a vesicle-mediated maintenance of store-operated calcium channels in a human embryonic kidney cell line
    Alderton, JM
    Ahmed, SA
    Smith, LA
    Steinhardt, RA
    [J]. CELL CALCIUM, 2000, 28 (03) : 161 - 169
  • [4] Injections of botulinum toxin type A produce pain alleviation in intractable trigeminal neuralgia
    Allam, N
    Brasil-Neto, JP
    Brown, G
    Tomaz, C
    [J]. CLINICAL JOURNAL OF PAIN, 2005, 21 (02) : 182 - 184
  • [5] Long-distance retrograde effects of botulinum neurotoxin A
    Antonucci, Flavia
    Rossi, Chiara
    Gianfranceschi, Laura
    Rossetto, Ornella
    Caleo, Matteo
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (14) : 3689 - 3696
  • [6] Aoki KR, 2003, HEADACHE, V43, pS9
  • [7] Can the Immunological Response to Botulinum Toxin Trigger Headaches?
    Baizabal-Carvallo, Jose Fidel
    [J]. NEUROTOXICITY RESEARCH, 2015, 27 (01) : 69 - 70
  • [8] Effect of Botulinum Toxin A on Proliferation and Apoptosis in the T47D Breast Cancer Cell Line
    Bandala, Cindy
    Martin Perez-Santos, Jose Luis
    Lara-Padilla, Eleazar
    Delgado Lopez, Ma. Guadalupe
    Anaya-Ruiz, Maricruz
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 891 - 894
  • [9] Baulmann J, 2000, NEUROSCIENCE, V95, P813
  • [10] Botulinum neurotoxin A: A review
    Berry, M. G.
    Stanek, Jan J.
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2012, 65 (10) : 1283 - 1291